Expression of phospholipases A2 in primary human lung macrophages. Role of cytosolic phospholipase A2-α in arachidonic acid release and platelet activating factor synthesis

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 2, 2009, Pages 92-102

  Giannattasio, Giorgio ^a   Lai, Ying ^b   Granata, Francescopaolo ^a   Mounier, Carine M ^c   Nallan, Laxman ^b   Oslund, Rob ^b   Leslie, Christina C ^d   Marone, Gianni ^a   Lambeau, Gérard ^c   Gelb, Michael H ^b   Triggiani, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Arachidonic acid; Eicosanoid; Inflammation; Lung macrophage; Phospholipase A2; Platelet activating factor

Indexed keywords

ARACHIDONIC ACID; BACTERIAL PROTEIN; CALCIUM IONOPHORE; ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; ME INDOXAM; MYCOBACTERIUM PROTEIN DERIVATIVE; PHORBOL ESTER; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 ALPHA; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; CARBAMIC ACID DERIVATIVE; INDOLIZINE DERIVATIVE; INDOXAM; IONOPHORE; PHOSPHOLIPASE A2 GROUP IV;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ANALYSIS; EXOCYTOSIS; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FLUOROIMMUNOASSAY; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

MYCOBACTERIUM;

ARACHIDONIC ACID; CARBAMATES; CELLS, CULTURED; ENZYME INHIBITORS; EXOCYTOSIS; FLUOROIMMUNOASSAY; GLUCURONIDASE; GROUP IV PHOSPHOLIPASES A2; HUMANS; IMMUNOBLOTTING; INDOLIZINES; IONOPHORES; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; PLATELET ACTIVATING FACTOR; POLYMERASE CHAIN REACTION;

EID: 59049099683     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.12.002     Document Type: Article

References (65)

1. Barnes P.J. Alveolar macrophages as orchestrators of COPD. COPD 1 (2004) 59-70
2. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am. J. Respir. Cell Mol. Biol. 31 (2004) 3-7
3. Reynolds H.Y. Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s. Am. J. Respir. Crit. Care Med. 171 (2005) 98-102
4. Marriott H.M., and Dockrell D.H. The role of the macrophage in lung disease mediated by bacteria. Exp. Lung Res. 33 (2007) 493-505
5. Sica A., Allavena P., and Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 267 (2008) 204-215
6. Balter M.S., Eschenbacher W.L., and Peters-Golden M. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. Am. Rev. Respir. Dis. 138 (1988) 1134-1142
7. Triggiani M., Oriente A., and Marone G. Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. J. Immunol. 152 (1994) 1394-1403
8. Peters-Golden M., and Henderson Jr. W.R. Leukotrienes. N. Engl. J. Med. 357 (2007) 1841-1854
9. Triggiani M., Schleimer R.P., Warner J.A., and Chilton F.H. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J. Immunol. 147 (1991) 660-666
10. Prescott S.M., Zimmerman G.A., Stafforini D.M., and McIntyre T.M. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69 (2000) 419-445
11. 2 superfamily and its group numbering system. Biochim. Biophys. Acta 1761 (2006) 1246-1259
12. 2. Prostaglandins Leukot. Essent. Fat. Acids 70 (2004) 373-376
13. 2 family. Prog. Lipid Res. 45 (2006) 487-510
14. 2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity. J. Biol. Chem. 273 (1998) 2184-2191
15. Pettus B.J., Bielawska A., Spiegel S., Roddy P., Hannun Y.A., and Chalfant C.E. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. J. Biol. Chem. 278 (2003) 38206-38213
16. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J. Biol. Chem. 269 (1994) 15625-15630
17. 2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J. Biol. Chem. 269 (1994) 15619-15624
18. 2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'. Bioorg. Med. Chem. Lett. 11 (2001) 587-590
19. 2. J. Med. Chem. 43 (2000) 1041-1044
20. 2 alpha blocks arachidonic acid release in a variety of mammalian cells. Biochim. Biophys. Acta 1513 (2001) 160-166
21. 2 based on a 1,3-disubstituted propan-2-one skeleton. J. Med. Chem. 45 (2002) 1348-1362
22. 2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J. Biol. Chem. 277 (2002) 5061-5073
23. 2-alpha does not regulate neutrophil NADPH oxidase activity. J. Biol. Chem. 280 (2005) 7519-7529
24. 2zeta in mouse lung fibroblasts. J. Biol. Chem. 282 (2007) 11676-11686
25. 2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J. Biol. Chem. 279 (2004) 16488-16494
26. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J. Exp. Med. 204 (2007) 865-877
27. 2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J. Immunol. 179 (2007) 4800-4807
28. 2 alpha activity that is responsible for arachidonic acid release. J. Biol. Chem. 278 (2003) 24153-24163
29. 2-alpha. J. Biol. Chem. 279 (2004) 25024-25038
30. 2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells. J. Biol. Chem. 281 (2006) 16245-16255
31. 2alpha activation. Blood 110 (2007) 561-567
32. 2 and their receptors and binding proteins. Biochim. Biophys. Acta 1488 (2000) 59-70
33. Humes J.L., Sadowski S., Galavage M., Goldenberg M., Subers E., Bonney R.J., and Kuehl Jr. F.A. Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. J. Biol. Chem. 257 (1982) 1591-1594
34. Peters-Golden M., and Shelly C. Inhibitory effect of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism. Role of ATP depletion. J. Immunol. 140 (1988) 1958-1966
35. Laviolette M., Carreau M., Coulombe R., Cloutier D., Dupont P., Rioux J., Braquet P., and Borgeat P. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages. J. Immunol. 141 (1988) 2104-2109
36. Elias J.A., Ferro T.J., Rossman M.D., Greenberg J.A., Daniele R.P., Schreiber A.D., and Freundlich B. Differential prostaglandin production by unfractionated and density-fractionated human monocytes and alveolar macrophages. J. Leukoc. Biol. 42 (1987) 114-121
37. Fathi M., Johansson A., Lundborg M., Orre L., Skold C.M., and Camner P. Functional and morphological differences between human alveolar and interstitial macrophages. Exp. Mol. Pathol. 70 (2001) 77-82
38. Ferrari-Lacraz S., Nicod L.P., Chicheportiche R., Welgus H.G., and Dayer J.M. Human lung tissue macrophages, but not alveolar macrophages, express matrix metalloproteinases after direct contact with activated T lymphocytes. Am. J. Respir. Cell Mol. Biol. 24 (2001) 442-451
39. Triggiani M., Giannattasio G., Balestrieri B., Loffredo S., Forte V., and Granata F. Phenotypical and functional heterogeneity of human lung macrophages. Clin. Exp. Allergy Rev. 4 (2004) 129-134
40. 2. J. Biol. Chem. 277 (2002) 48535-48549
41. 2. Biochemistry 37 (1998) 8516-8526
42. 2 induce β-glucuronidase release and IL-6 production from human lung macrophages. J. Immunol. 164 (2000) 4908-4915
43. 2-III as a biomarker candidate. Br. J. Cancer 98 (2008) 587-595
44. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J. Biol. Chem. 270 (1995) 15359-15367
45. 2 in regulating arachidonic acid release in macrophages. J. Biol. Chem. 273 (1998) 8203-8211
46. Werz O., Klemm J., Samuelsson B., and Radmark O. Phorbol ester up-regulates capacities for nuclear translocation and phosphorylation of 5-lipoxygenase in Mono Mac 6 cells and human polymorphonuclear leukocytes. Blood 97 (2001) 2487-2495
47. Yoss E.B., Spannhake E.W., Flynn J.T., Fish J.E., and Peters S.P. Arachidonic acid metabolism in normal human alveolar macrophages: stimulus specificity for mediator release and phospholipid metabolism, and pharmacologic modulation in vitro and in vivo. Am. J. Respir. Cell Mol. Biol. 2 (1990) 69-80
48. Ellner J.J. Regulation of the human immune response during tuberculosis. J. Lab. Clin. Med. 130 (1997) 469-475
49. Aung H., Toossi Z., Wisnieski J.J., Wallis R.S., Culp L.A., Phillips N.B., Phillips M., Averill L.E., Daniel T.M., and Ellner J.J. Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. J. Clin. Invest. 98 (1996) 1261-1268
50. Stenger S., and Modlin R.L. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr. Opin. Immunol. 14 (2002) 452-457
51. Valera I., Vigo A.G., Alonso S., Barbolla L., Crespo M.S., and Fernandez N. Peptidoglycan and mannose-based molecular patterns trigger the arachidonic acid cascade in human polymorphonuclear leukocytes. J. Leukoc. Biol. 81 (2007) 925-933
52. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1 (2001) 135-145
53. Brown G.P., Monick M.M., and Hunninghake G.W. Human alveolar macrophage arachidonic acid metabolism. Am. J. Physiol. 254 (1988) C809-815
54. 2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J. Biol. Chem. 280 (2005) 38969-38975
55. 2. J. Immunol. 151 (1993) 5639-5652
56. 2. J. Clin. Invest. 91 (1993) 2118-2125
57. 2. Cell Signal. 14 (2002) 199-204
58. 2, cyclooxygenase-1 and -2 expression by PMA, TNFalpha, LPS and M-CSF in human monocytes and macrophages. Mol. Cell. Biochem. 246 (2003) 31-38
59. Lu Y., Bottari P., Turecek F., Aebersold R., and Gelb M.H. Absolute quantification of specific proteins in complex mixtures using visible isotope-coded affinity tags. Anal. Chem. 76 (2004) 4104-4111
60. Kaplan J., and Ward D.M. Movement of receptors and ligands through the endocytic apparatus in alveolar macrophages. Am. J. Physiol. 258 (1990) L263-270
61. 2 protein interaction. J. Clin. Invest. 102 (1998) 1152-1160
62. Chilton F.H., Averill F.J., Hubbard W.C., Fonteh A.N., Triggiani M., and Liu M.C. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 183 (1996) 2235-2245
63. Dziarski R., and Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73 (2005) 5212-5216
64. 2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8527-8531
65. 2 produce spermatozoa with impaired motility and have greatly reduced fertility. J. Biol. Chem. 279 (2004) 38194-38200